Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential-Reference-Cited by-同舟云学术

Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential

Published:2017-02-18 Issue:14 Volume:8 Page:23048-23060
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Hailong¹²,Sun Qianwen³,Zhang Mingshan¹,Zhang Zhihua¹²,Fan Xinyi²,Yuan Hongyu²,Li Cheng¹,Guo Yuduo¹,Ning Weihai¹,Sun Youliang⁴,Song Yongmei²,Yu Chunjiang¹

Affiliation:

1. Department of Neurosurgery, Sanbo Brain Hospital Capital Medical University, Beijing, P.R. China

2. State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China

3. Department of Neurology, Qilu Hospital Shandong University, Jinan, P.R. China

4. School of Basic Medical Science, Capital Medical University, Beijing, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier;Neuro-Oncology Advances;2024-01-01

2. Global metabolomics study on the pathogenesis of pediatric medulloblastoma via UPLC- Q/E-MS/MS;PLOS ONE;2023-06-15

3. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor;International Journal of Pharmaceutics;2022-09

4. Association between vitamins and risk of brain tumors: A systematic review and dose-response meta-analysis of observational studies;Frontiers in Nutrition;2022-07-29

5. Q-TOF LC/MS-based Untargeted Metabolomics Approach to Evaluate the Effect of Folate-Conjugated Cyclodextrins on Triple-Negative Breast Cancer Cells;Current Pharmaceutical Analysis;2021-12